Designed for use in hospitals and ambulatory surgical centers, the FDR Cross may help improve workflows and efficiency for image-guided procedures.
Fujifilm Healthcare Americas Corporation has launched the FDR Cross, a portable device that combines digital radiography and fluoroscopic capabilities in one platform.
Reducing the need for additional equipment for image-guided procedures, the FDR Cross system features a unique hybrid c-arm that allows clinicians to obtain fluoroscopic imaging and radiographs from one device, according to Fujifilm Healthcare Americas Corporation. The company noted that the hybrid c-arm is part of an ergonomic design that can be wireless for up to eight hours and is more than 150 pounds lighter than conventional compact c-arms.
“ … the FDR Cross is our latest innovation in enhanced, portable imaging, designed to speed clinician workflows and improve patient care,” noted Rob Fabrizo, director of strategic marketing for medical imaging systems at Fujifilm Healthcare Americas Corporation. “The FDR Cross allows healthcare organizations to maximize equipment utilization by performing fluoroscopic verification and portable imaging with a single imaging system.”
Fujifilm Healthcare Americas Corporation said the FDR Cross will be showcased at the AHRA 50th Annual Meeting and Exposition July 10-13 in Phoenix.
The company noted that other features of the FDR Cross include the use of a 17 x 17-inch detector, which reportedly doubles the imaging area size in comparison to other c-arm devices. An interchangeable detector holder also enables radiologists and clinicians to switch between three different detector sizes to accommodate different exams and procedures in the OR, according to Fujifilm Healthcare Americas Corporation.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.